Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

IDEXX Laboratories, Inc. (IDXX) had Revenue of $3.66B for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$3.66B
Net Income	$845.04M
Cost of Goods Sold	$1.47B
Gross Profit	$2.19B
Operating Expenses	$2.56B
Operating Income	$1.10B
Non-Operating Income/Expense	$-35.95M
Pre-Tax Income	$1.06B
Normalized Pre-Tax Income	$1.06B
Income after Taxes	$845.04M
Income from Continuous Operations	$845.04M
Consolidated Net Income/Loss	$845.04M
Normalized Income after Taxes	$845.04M
EBIT	$1.10B
EBITDA	$1.21B
Weighted-Average Shares Outstanding (Basic)	83.07M
Weighted-Average Shares Outstanding (Diluted)	83.98M
Earnings per Share (EPS) (Basic)	$10.17
Earnings per Share (EPS) (Diluted)	$10.06
Balance Sheet Financials
Current Assets	$1.50B
Property, Plant, and Equipment	$702.18M
Long-Term Assets	$1.76B
Total Assets	$3.26B
Current Liabilities	$951.55M
Long-Term Debt	$622.88M
Long-Term Liabilities	$823.85M
Total Liabilities	$1.78B
Common Equity	$1.48B
Tangible Shareholders Equity	$1.03B
Shareholders Equity	$1.48B
Common Shares Outstanding	83.03M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$906.51M
Cash Flow from Investing Activities	$-125.25M
Cash Flow from Financial Activities	$-442.00M
Beginning Cash	$112.55M
End Cash	$453.93M
Increase/Decrease in Cash	$341.39M
Stock-Based Compensation	$59.74M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.57
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.30
Debt to Equity Ratio	0.64
Gross Margin	59.82%
Operating Margin	29.97%
EBIT Margin	29.97%
EBITDA Margin	33.11%
Pre-Tax Profit Margin	28.99%
Profit Margin	23.08%
Free Cash Flow	$772.88M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.12
Inventory Turnover	3.87
Receiveable Turnover	8.00
Days Sales in Receivables	45.61
Return on Equity	56.92%
Return on Tangible Equity	81.72%
Return on Assets	25.92%
Return on Investments	40.10%
Book Value Per Share	$17.88
Free Cash Flow per Share	$9.20
Operating Cash Flow per Share	$10.79

Data from Zacks Investment Research, Inc.